Abiopharma

🔍 Stejskal Jessica Anne (Executive)

Company: Bridgewater Bancshares Inc (BWB)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 1,600 shares of Common Stock at $7.47 per share (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,607.00 | transaction_form_type: 4
• Sold 1,600 shares of Option to buy at $7.47 per share (Derivative)
  Date: 2026-07-30 | Code: M | Expires: 2027-09-30 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 10,000 shares of Option to buy at $10.65 per share (Derivative)
  Date: 2026-07-30 | Code: H | Expires: 2033-08-01 | shares_owned_after: 10,000.00 | Footnotes: F3, F4
• Holds 25,000 shares of Option to buy at $13.78 per share (Derivative)
  Date: 2026-07-30 | Code: H | Expires: 2035-02-03 | shares_owned_after: 25,000.00 | Footnotes: F3, F5

Footnotes:

• F1: Option to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Plan.
• F2: Option exercisable in 20% increments on the first five anniversaries of the date of the grant which was10/1/2017.
• F3: Option to buy granted under the 2023 Equity Incentive Plan.
• F4: Option exercisable in 25% increments on the first four anniversaries of the date of the grant which was 8/1/2023.
• F5: Option exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/3/2025.